Tour de Cure and Woolworths Group celebrate milestone 50th research breakthrough in the fight against cancer
Monday, 4 October 2021: Tour de Cure has achieved its fiftieth cancer research breakthrough, made possible by the support of Woolworths Group’s team members and partners.
The breakthrough relates to a new treatment for secondary bone cancers (osteosarcomas) where the cancer has spread from the bones to other parts of the body.
Associate Professor Christine Hawkins at La Trobe University for Molecular Science made a significant step in evaluating ‘Smac mimetic treatment’ for metastatic osteosarcoma. Outcomes for osteosarcoma patients have not improved since the 1980s and the cancer is fatal for over a third of patients. With one in two Australians impacted by cancer, Tour de Cure understands the devastating impact this disease can have on families across the country.
Professor Hawkins said: “This new treatment was tested for the first time in osteosarcoma and has been more effective in treating animal models then the best currently used chemotherapy drugs.
“This breakthrough means that we can now target secondary osteosarcomas and it could lead to new options for patients who cannot be cured using other treatments.”
The finding was made possible by a $100,000 grant raised by Woolworths Group’s team members and suppliers through its Woolies Wheels & Walks fundraiser. Over 2,000 team members and business partners have taken part in the three-day ride or one-day walk event in recent years, donating more than $2.8 million to support cancer research.
Woolies Wheels & Walks Co-Chair and Woolworths Group Director of Property, Ralph Kemmler said: “We are humbled to play a small part in helping make this incredible breakthrough possible and contribute to a better tomorrow for people diagnosed with cancer. We’re proud of our team members and suppliers who have got behind Tour de Cure through the Woolies Wheels & Walks fundraiser and shown what’s possible when we work together for a good cause.
“It’s hugely rewarding to see the results of our fundraising and has made us even more motivated to hit the road again next year to support more Tour de Cure breakthroughs like this.”
Tour de Cure CEO, Simon Rountree added: “While we are celebrating this significant step forward, there is still so much more to do if we want to end the fight against cancer.
“The result of this partnership with Woolies demonstrates the impact we can have on making progress. The only barrier we face is the lack of funding for brilliant research minds like Associate Professor Hawkins.”
Tour de Cure has raised more than $75 million and funded 563 research projects through the generosity of its community and corporate partners. With ongoing support, it will continue to work towards a cure and change the lives of people suffering from cancer. To donate and for more information go to tourdecure.com.au.
Contact: Laura Preston 0403 955 562 firstname.lastname@example.org